Omnicell Return on Tangible Equity 2010-2024 | OMCL
Current and historical return on tangible equity values for Omnicell (OMCL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Omnicell Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-06-30 |
$-0.02B |
$0.27B |
-8.06% |
| 2024-03-31 |
$-0.02B |
$0.25B |
-9.08% |
| 2023-12-31 |
$-0.02B |
$0.24B |
-9.41% |
| 2023-09-30 |
$-0.03B |
$0.23B |
-17.87% |
| 2023-06-30 |
$-0.02B |
$0.20B |
-13.53% |
| 2023-03-31 |
$-0.02B |
$0.17B |
-11.79% |
| 2022-12-31 |
$0.01B |
$0.15B |
5.12% |
| 2022-09-30 |
$0.05B |
$0.15B |
43.05% |
| 2022-06-30 |
$0.06B |
$0.10B |
42.18% |
| 2022-03-31 |
$0.07B |
$0.07B |
32.68% |
| 2021-12-31 |
$0.08B |
$0.13B |
26.69% |
| 2021-09-30 |
$0.08B |
$0.28B |
23.87% |
| 2021-06-30 |
$0.06B |
$0.40B |
15.55% |
| 2021-03-31 |
$0.04B |
$0.35B |
8.99% |
| 2020-12-31 |
$0.03B |
$0.30B |
7.85% |
| 2020-09-30 |
$0.04B |
$0.47B |
8.86% |
| 2020-06-30 |
$0.05B |
$0.44B |
12.33% |
| 2020-03-31 |
$0.07B |
$0.42B |
18.97% |
| 2019-12-31 |
$0.06B |
$0.38B |
18.97% |
| 2019-09-30 |
$0.05B |
$0.34B |
19.60% |
| 2019-06-30 |
$0.05B |
$0.30B |
21.55% |
| 2019-03-31 |
$0.04B |
$0.26B |
22.81% |
| 2018-12-31 |
$0.04B |
$0.20B |
31.08% |
| 2018-09-30 |
$0.06B |
$0.13B |
62.86% |
| 2018-06-30 |
$0.05B |
$0.10B |
108.89% |
| 2018-03-31 |
$0.04B |
$0.07B |
880.00% |
| 2017-12-31 |
$0.03B |
$0.05B |
-98.41% |
| 2017-09-30 |
$0.01B |
$-0.04B |
-13.85% |
| 2017-06-30 |
$0.00B |
$-0.06B |
-4.08% |
| 2017-03-31 |
$-0.00B |
$-0.07B |
0.00% |
| 2016-12-31 |
$0.01B |
$-0.09B |
-11.14% |
| 2016-09-30 |
$0.01B |
$-0.07B |
-33.33% |
| 2016-06-30 |
$0.02B |
$-0.09B |
52.63% |
| 2016-03-31 |
$0.03B |
$-0.11B |
27.55% |
| 2015-12-31 |
$0.03B |
$0.17B |
18.42% |
| 2015-09-30 |
$0.03B |
$0.15B |
18.47% |
| 2015-06-30 |
$0.03B |
$0.16B |
17.37% |
| 2015-03-31 |
$0.03B |
$0.20B |
16.09% |
| 2014-12-31 |
$0.03B |
$0.19B |
16.74% |
| 2014-09-30 |
$0.03B |
$0.17B |
16.28% |
| 2014-06-30 |
$0.03B |
$0.19B |
17.06% |
| 2014-03-31 |
$0.03B |
$0.17B |
17.09% |
| 2013-12-31 |
$0.02B |
$0.16B |
16.41% |
| 2013-09-30 |
$0.02B |
$0.16B |
17.04% |
| 2013-06-30 |
$0.02B |
$0.14B |
18.57% |
| 2013-03-31 |
$0.02B |
$0.13B |
16.11% |
| 2012-12-31 |
$0.02B |
$0.11B |
11.55% |
| 2012-09-30 |
$0.01B |
$0.10B |
8.08% |
| 2012-06-30 |
$0.01B |
$0.09B |
4.76% |
| 2012-03-31 |
$0.01B |
$0.26B |
4.84% |
| 2011-12-31 |
$0.01B |
$0.25B |
4.55% |
| 2011-09-30 |
$0.01B |
$0.25B |
3.37% |
| 2011-06-30 |
$0.01B |
$0.24B |
2.58% |
| 2011-03-31 |
$0.01B |
$0.23B |
2.17% |
| 2010-12-31 |
$0.01B |
$0.23B |
2.20% |
| 2010-09-30 |
$0.01B |
$0.23B |
2.24% |
| 2010-06-30 |
$0.01B |
$0.23B |
2.28% |
| 2010-03-31 |
$0.00B |
$0.22B |
1.86% |
| 2009-12-31 |
$0.00B |
$0.21B |
0.48% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$2.263B |
$1.147B |
|
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
|
